BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND HLF, Q16534, 3131, ENSG00000108924
119 results:

  • 1. Updates on lymphoblastic leukemia/lymphoma classification and minimal/measurable residual disease analysis.
    Kovach AE; Wood BL
    Semin Diagn Pathol; 2023 Nov; 40(6):457-471. PubMed ID: 37953192
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tensin 1 regulated by hepatic leukemia factor represses the progression of prostate cancer.
    Zhou H; Wang F
    Mutagenesis; 2023 Dec; 38(6):295-304. PubMed ID: 37712764
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. hlf promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway.
    Han T; Chen T; Chen L; Li K; Xiang D; Dou L; Li H; Gu Y
    Cell Death Dis; 2023 Sep; 14(9):606. PubMed ID: 37709768
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. miRNA-103-3p-hlf regulates apoptosis and autophagy by targeting hepatic leukaemia factor in heart failure.
    Xue P; Liu Y; Wang H; Huang J; Luo M
    ESC Heart Fail; 2023 Oct; 10(5):3038-3045. PubMed ID: 37562973
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
    Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
    Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunostimulation with chemotherapy of a ruthenium-arene complex via blockading CD47 signal in chronic myelogenous leukemia cells.
    Hu G; Lv M; Guo B; Huang Y; Su Z; Qian Y; Xue X; Liu HK
    J Inorg Biochem; 2023 Jun; 243():112195. PubMed ID: 36996696
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. m6A RNA methylation-mediated upregulation of hlf promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/β-catenin signaling pathway.
    Xiang D; Gu M; Liu J; Dong W; Yang Z; Wang K; Fu J; Wang H
    Cancer Lett; 2023 Apr; 560():216144. PubMed ID: 36958694
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation for a Patient With Tcf3-hlf-Positive Acute Lymphoblastic leukemia Extramedullary Relapse After Unrelated Bone Marrow Transplantation.
    Takahashi N; Mochizuki K; Kobayashi S; Ohara Y; Kudo S; Saito Y; Ikeda K; Ohto H; Kikuta A; Sano H
    J Pediatr Hematol Oncol; 2023 Apr; 45(3):e419-e422. PubMed ID: 36162014
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hepatic leukemia factor-expressing paraxial mesoderm cells contribute to the developing brain vasculature.
    Koui Y; Ideue T; Boylan M; Anderson MJ; Osato M; Suda T; Yokomizo T; Mukouyama YS
    Biol Open; 2022 Sep; 11(9):. PubMed ID: 36017733
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic leukemia.
    Jędraszek K; Malczewska M; Parysek-Wójcik K; Lejman M
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328487
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.
    Padella A; Ghelli Luserna Di Rorà A; Marconi G; Ghetti M; Martinelli G; Simonetti G
    J Hematol Oncol; 2022 Jan; 15(1):10. PubMed ID: 35065680
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. hlf regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
    Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
    J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. FLT3-ITD allelic ratio and hlf expression predict FLT3 inhibitor efficacy in adult AML.
    Kivioja J; Malani D; Kumar A; Kontro M; Parsons A; Kallioniemi O; Heckman CA
    Sci Rep; 2021 Dec; 11(1):23565. PubMed ID: 34876631
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy.
    Leahy AB; Devine KJ; Li Y; Liu H; Myers R; DiNofia A; Wray L; Rheingold SR; Callahan C; Baniewicz D; Patino M; Newman H; Hunger SP; Grupp SA; Barrett DM; Maude SL
    Blood; 2022 Apr; 139(14):2173-2185. PubMed ID: 34871373
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. hlf expression defines the human hematopoietic stem cell state.
    Lehnertz B; Chagraoui J; MacRae T; Tomellini E; Corneau S; Mayotte N; Boivin I; Durand A; Gracias D; Sauvageau G
    Blood; 2021 Dec; 138(25):2642-2654. PubMed ID: 34499717
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencing.
    Salim M; Heldt F; Thomay K; Lentes J; Behrens YL; Kaune B; Möricke A; Cario G; Schieck M; Hofmann W; Davenport C; Steinemann D; Schrappe M; Schlegelberger B; Göhring G
    Genes Chromosomes Cancer; 2022 Jan; 61(1):22-26. PubMed ID: 34460133
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Successful Treatment of TCF3-hlf-positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell Therapy.
    Wang T; Wan X; Yang F; Shi W; Liu R; Ding L; Tang Y; Luo C; Yang X; Ma Y; Wang X; Liang H; Li B; Lu J; Chen J
    Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):386-392. PubMed ID: 33640284
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. High Hepatic leukemia factor expression indicates a favorable survival in glioma patients.
    Liu Q; Ge H; Liu P; Li Y
    Medicine (Baltimore); 2021 Feb; 100(6):e23980. PubMed ID: 33578515
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia.
    Louka E; Povinelli B; Rodriguez-Meira A; Buck G; Wen WX; Wang G; Sousos N; Ashley N; Hamblin A; Booth CAG; Roy A; Elliott N; Iskander D; de la Fuente J; Fordham N; O'Byrne S; Inglott S; Norfo R; Salio M; Thongjuea S; Rao A; Roberts I; Mead AJ
    J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33416891
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.